全文获取类型
收费全文 | 11412篇 |
免费 | 660篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 168篇 |
妇产科学 | 200篇 |
基础医学 | 1722篇 |
口腔科学 | 1028篇 |
临床医学 | 938篇 |
内科学 | 2604篇 |
皮肤病学 | 250篇 |
神经病学 | 760篇 |
特种医学 | 205篇 |
外科学 | 1345篇 |
综合类 | 36篇 |
一般理论 | 5篇 |
预防医学 | 1178篇 |
眼科学 | 117篇 |
药学 | 883篇 |
中国医学 | 146篇 |
肿瘤学 | 351篇 |
出版年
2023年 | 137篇 |
2022年 | 236篇 |
2021年 | 453篇 |
2020年 | 292篇 |
2019年 | 382篇 |
2018年 | 479篇 |
2017年 | 321篇 |
2016年 | 342篇 |
2015年 | 398篇 |
2014年 | 517篇 |
2013年 | 678篇 |
2012年 | 942篇 |
2011年 | 1091篇 |
2010年 | 510篇 |
2009年 | 411篇 |
2008年 | 651篇 |
2007年 | 669篇 |
2006年 | 574篇 |
2005年 | 493篇 |
2004年 | 395篇 |
2003年 | 333篇 |
2002年 | 331篇 |
2001年 | 211篇 |
2000年 | 211篇 |
1999年 | 167篇 |
1998年 | 44篇 |
1997年 | 43篇 |
1996年 | 23篇 |
1995年 | 29篇 |
1994年 | 37篇 |
1993年 | 23篇 |
1992年 | 89篇 |
1991年 | 55篇 |
1990年 | 60篇 |
1989年 | 53篇 |
1988年 | 37篇 |
1987年 | 27篇 |
1986年 | 28篇 |
1985年 | 31篇 |
1984年 | 21篇 |
1980年 | 17篇 |
1979年 | 15篇 |
1978年 | 22篇 |
1975年 | 17篇 |
1974年 | 15篇 |
1973年 | 22篇 |
1971年 | 22篇 |
1970年 | 17篇 |
1969年 | 18篇 |
1967年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
José Wellington Alves dos Santos Fabiani Palagi Machado Felipe Schaich Douglas Zaione Nascimento Tiago Teixeira Simon Luis Fernando Cibin Keli Cristina Mann Vinícius André Guerra Mateus Correa Marcos Ferreira Gazzoni Marta Pires da Rocha Melissa Daubermann Falster Ronaldo Manfredini Vassoler 《Respiratory Medicine Extra》2007,3(4):186-188
122.
Vernica Frana Diniz Rocha Thiago Pereira Cavalcanti Jailton Azevedo Helena Ferreira Leal Giulyana Evelyn Oliveira Silva Allan Roberto Xavier Malheiros Ledilce Almeida Ataide Jos Admiro Lima Filho Antonio Raimundo Pinto Almeida Nadia de Andrade Khouri Mitermayer Galvo Reis Joice Neves Reis 《The American journal of tropical medicine and hygiene》2021,104(3):848
123.
Felipe V. Gomes Ana Carolina Issy Frederico R. Ferreira Maria-Paz Viveros Elaine A. Del Bel Francisco S. Guimar?es 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(5)
Background:
Preclinical and clinical data suggest that cannabidiol (CBD), a major non-psychotomimetic compound from Cannabis sativa, induces antipsychotic-like effects. However, the antipsychotic properties of repeated CBD treatment have been poorly investigated. Behavioral changes induced by repeated treatment with glutamate N-methyl-D-aspartate receptor (NMDAR) antagonists have been proposed as an animal model of schizophrenia-like signs. In the present study, we evaluated if repeated treatment with CBD would attenuate the behavioral and molecular modifications induced by chronic administration of one of these antagonists, MK-801.Methods:
Male C57BL/6J mice received daily i.p. injections of MK-801 (0.1, 0.5, or 1mg/kg) for 14, 21, or 28 days. Twenty-four hours after the last injection, animals were submitted to the prepulse inhibition (PPI) test. After that, we investigated if repeated treatment with CBD (15, 30, and 60mg/kg) would attenuate the PPI impairment induced by chronic treatment with MK-801 (1mg/kg; 28 days). CBD treatment began on the 6th day after the start of MK-801 administration and continued until the end of the treatment. Immediately after the PPI, the mice brains were removed and processed to evaluate the molecular changes. We measured changes in FosB/ΔFosB and parvalbumin (PV) expression, a marker of neuronal activity and a calcium-binding protein expressed in a subclass of GABAergic interneurons, respectively. Changes in mRNA expression of the NMDAR GluN1 subunit gene (GRN1) were also evaluated. CBD effects were compared to those induced by the atypical antipsychotic clozapine.Results:
MK-801 administration at the dose of 1mg/kg for 28 days impaired PPI responses. Chronic treatment with CBD (30 and 60mg/kg) attenuated PPI impairment. MK-801 treatment increased FosB/ΔFosB expression and decreased PV expression in the medial prefrontal cortex. A decreased mRNA level of GRN1 in the hippocampus was also observed. All the molecular changes were attenuated by CBD. CBD by itself did not induce any effect. Moreover, CBD effects were similar to those induced by repeated clozapine treatment.Conclusions:
These results indicate that repeated treatment with CBD, similar to clozapine, reverses the psychotomimetic-like effects and attenuates molecular changes observed after chronic administration of an NMDAR antagonist. These data support the view that CBD may have antipsychotic properties. 相似文献124.
125.
Clia Domingues Maria Joo Vidigal Ferreira Joana Moura Ferreira Ana Vera Marinho Patrícia Marques Alves Ctia Ferreira Isabel Fonseca Lino Gonalves 《Arquivos brasileiros de cardiologia》2021,116(5):928
Background:Although non-ischemic troponin elevation is frequently seen in patients admitted to the emergency department (ED), consensus regarding its management is lacking.Objectives:This study aimed to characterize patients admitted to the ED with non-ischemic troponin elevation and to identify potential mortality predictors in this population.Methods:This retrospective observational study included ED patients with a positive troponin test result between June and July of 2015. Patients with a clinical diagnosis of acute coronary syndrome (ACS) were excluded. Data on patient demographics and clinical and laboratory variables were extracted from medical records. Follow-up data were obtained for 16 months or until death occurred. The statistical significance level was 5%.Results:Troponin elevation without ACS was found in 153 ED patients. The median (IQR) patient age was 78 (19) years, 80 (52.3%) were female and 59(38.6%) died during follow-up. The median (IQR) follow-up period was 477(316) days. Survivors were significantly younger 76 (24) vs. 84 (13) years; p=0.004) and featured a higher proportion of isolated troponin elevation (without creatine kinase or myoglobin elevation) in two consecutive evaluations: 48 (53.9%) vs. 8 (17.4%), p<0.001. Survivors also presented a lower rate of antiplatelet treatment and same-day hospitalization. In the multivariate logistic regression with adjustment for significant variables in the univariate analysis, isolated troponin elevation in two consecutive evaluations showed a hazard ratio= 0.43 (95%CI 0.17–0.96, p=0.039); hospitalization, previous antiplatelet treatment and age remained independently associated with mortality.Conclusions:Isolated troponin elevation in two consecutive measurements was a strong predictor of survival in ED patients with troponin elevation but without ACS. 相似文献
126.
127.
Jo?o Alves de Araújo-Filho Arioldo Carvalho Vasconcelos-Jr Eduardo Martins de Sousa Colombina da Silveira Patrícia Tavares Pereira de Sousa Klaus Andrade Severo Ludmila Ferreira Vieira André Kipnis Ana Paula Junqueira-Kipnis 《The Brazilian journal of infectious diseases》2008,12(1):94-98
Multidrug-resistant tuberculosis (MDR-TB) is an emerging and worrisome health problem that threatens tuberculosis (TB) control worldwide. The clinical management of MDR-TB is a complex issue associated with the use of multiple drugs for a long period, usually accompanied by side effects and high costs. The objective of this work was to relate cases of MDR-TB occurring in Goiás, a central state of Brazil. We related five cases of MDR-TB, three women and two men. All were pulmonary cases. Three were in their second treatment and two in their first treatment. Surgical pulmonary resection was performed in one case. One death occurred. Lack of adherence, gastric intolerance to anti-TB drugs and poor clinical management were the main aspects related to the emergent resistance. A revision of the main clinical aspects of this disease was performed. 相似文献
128.
Sara Huber Roland Lang Markus Steiner Lorenz Aglas Fatima Ferreira Michael Wallner Thomas Hawranek Gabriele Gadermaier 《Clinical and translational allergy》2018,8(1):39
Background
The clinical benefit of allergen-specific immunotherapy (AIT) involves induction of blocking antibodies. It is not clear if these antibodies function via steric hindrance alone or a combination of levels, avidities, and epitope specificities, and clinical outcome cannot be predicted. We aim to in-depth characterize serum antibody profiles during birch pollen AIT, investigate therapy-induced antibodies for their capacity to block IgE binding to Bet v 1 and correlate data with clinical outcomes.Methods
Immune responses of five birch pollen allergic patients were monitored during the first year of AIT by nasal provocation tests (NPTs), ImmunoCAP, immunoblots, direct and avidity enzyme-linked immunosorbent assays, mediator release assays, facilitated antigen binding (FAB) assays, and inhibition mediator release assays.Results
There was no correlation between NPT results and therapy-induced changes in levels (IgE, IgG, IgA, IgM), avidities, or mediator release potency of Bet v 1-specific antibodies. In FAB assays, blocking antibodies initiated upon AIT were shown to prevent formation of Bet v 1-IgE complexes of an indicator serum pool and significantly correlated with clinical readout. Inhibition mediator release assays using patient-specific IgE for passive sensitization revealed therapy-induced blocking capacities with very good correlation to NPT results. Notably, this assay was the only one to detect a non-responder during treatment in this pilot study.Conclusions
Clinical outcome of AIT depends on induction of blocking antibodies able to prevent the patient’s own IgE from allergen binding. Monitoring of clinical efficacy seems to be best achieved using the inhibition mediator release assay, as development of relevant blocking antibodies can be verified in a patient-tailored manner.129.
Masliza Mahmod Nikhil Pal Jennifer Rayner Cameron Holloway Betty Raman Sairia Dass Eylem Levelt Rina Ariga Vanessa Ferreira Rajarshi Banerjee Jurgen E. Schneider Christopher Rodgers Jane M. Francis Theodoros D. Karamitsos Michael Frenneaux Houman Ashrafian Stefan Neubauer Oliver Rider 《Journal of cardiovascular magnetic resonance》2018,20(1):88
Background
Heart failure (HF) is characterized by altered myocardial substrate metabolism which can lead to myocardial triglyceride accumulation (steatosis) and lipotoxicity. However its role in mild HF with preserved ejection fraction (HFpEF) is uncertain. We measured myocardial triglyceride content (MTG) in HFpEF and assessed its relationships with diastolic function and exercise capacity.Methods
Twenty seven HFpEF (clinical features of HF, left ventricular EF >50%, evidence of mild diastolic dysfunction and evidence of exercise limitation as assessed by cardiopulmonary exercise test) and 14 controls underwent 1H-cardiovascular magnetic resonance spectroscopy (1H-CMRS) to measure MTG (lipid/water, %), 31P-CMRS to measure myocardial energetics (phosphocreatine-to-adenosine triphosphate - PCr/ATP) and feature-tracking cardiovascular magnetic resonance (CMR) imaging for diastolic strain rate.Results
When compared to controls, HFpEF had 2.3 fold higher in MTG (1.45?±?0.25% vs. 0.64?±?0.16%, p?=?0.009) and reduced PCr/ATP (1.60?±?0.09 vs. 2.00?±?0.10, p?=?0.005). HFpEF had significantly reduced diastolic strain rate and maximal oxygen consumption (VO2 max), which both correlated significantly with elevated MTG and reduced PCr/ATP. On multivariate analyses, MTG was independently associated with diastolic strain rate while diastolic strain rate was independently associated with VO2 max.Conclusions
Myocardial steatosis is pronounced in mild HFpEF, and is independently associated with impaired diastolic strain rate which is itself related to exercise capacity. Steatosis may adversely affect exercise capacity by indirect effect occurring via impairment in diastolic function. As such, myocardial triglyceride may become a potential therapeutic target to treat the increasing number of patients with HFpEF.130.
Henrique de Alencar Gomes Bruno de Souza Moreira Rosana Ferreira Sampaio Sheyla Rossana Cavalcanti Furtado Sebastião Cronemberger Roberto de Alencar Gomes Renata Noce Kirkwood 《Revista brasileira de fisioterapia (S?o Carlos (S?o Paulo, Brazil))》2018,22(5):376-382